Standard
Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH). / Klose, H; Opitz, C; Bremer, H; Ewert, R; Bonderman, D; Rosenkranz, S; Seeger, W; Schmeißer, A; Harbaum, L; Buerke, M; Ghofrani, H Ardeschir; Borst, M M; Leuchte, H H; Lange, T J; Behr, J; Ulrich, S; Lang, I; Olschewski, H; Gall, H; Kabitz, H-J; Kleber, F-X; Held, M; Hoeper, M M; Grünig, E.
In:
DEUT MED WOCHENSCHR, Vol. 139 Suppl 4, 01.12.2014, p. S142-50.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
Harvard
Klose, H, Opitz, C, Bremer, H, Ewert, R, Bonderman, D, Rosenkranz, S, Seeger, W, Schmeißer, A
, Harbaum, L, Buerke, M, Ghofrani, HA, Borst, MM, Leuchte, HH, Lange, TJ, Behr, J, Ulrich, S, Lang, I, Olschewski, H, Gall, H, Kabitz, H-J, Kleber, F-X, Held, M, Hoeper, MM & Grünig, E 2014, '
Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH)',
DEUT MED WOCHENSCHR, vol. 139 Suppl 4, pp. S142-50.
https://doi.org/10.1055/s-0034-1387489
APA
Klose, H., Opitz, C., Bremer, H., Ewert, R., Bonderman, D., Rosenkranz, S., Seeger, W., Schmeißer, A.
, Harbaum, L., Buerke, M., Ghofrani, H. A., Borst, M. M., Leuchte, H. H., Lange, T. J., Behr, J., Ulrich, S., Lang, I., Olschewski, H., Gall, H., ... Grünig, E. (2014).
Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH).
DEUT MED WOCHENSCHR,
139 Suppl 4, S142-50.
https://doi.org/10.1055/s-0034-1387489
Vancouver
Bibtex
@article{eac06fc25cf94cdabba9a6f0e01dc0da,
title = "Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH)",
keywords = "Adult, Antihypertensive Agents, Combined Modality Therapy, Cooperative Behavior, Drug Approval, Drug Therapy, Combination, Endothelin Receptor Antagonists, Evidence-Based Medicine, Humans, Hypertension, Pulmonary, Interdisciplinary Communication, Molecular Targeted Therapy, Phosphodiesterase 5 Inhibitors, Pyrazoles, Pyrimidines, Randomized Controlled Trials as Topic, Survival Rate, Treatment Outcome",
author = "H Klose and C Opitz and H Bremer and R Ewert and D Bonderman and S Rosenkranz and W Seeger and A Schmei{\ss}er and L Harbaum and M Buerke and Ghofrani, {H Ardeschir} and Borst, {M M} and Leuchte, {H H} and Lange, {T J} and J Behr and S Ulrich and I Lang and H Olschewski and H Gall and H-J Kabitz and F-X Kleber and M Held and Hoeper, {M M} and E Gr{\"u}nig",
year = "2014",
month = dec,
day = "1",
doi = "10.1055/s-0034-1387489",
language = "Deutsch",
volume = "139 Suppl 4",
pages = "S142--50",
journal = "DEUT MED WOCHENSCHR",
issn = "0012-0472",
publisher = "Georg Thieme Verlag KG",
}
RIS
TY - JOUR
T1 - Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH)
AU - Klose, H
AU - Opitz, C
AU - Bremer, H
AU - Ewert, R
AU - Bonderman, D
AU - Rosenkranz, S
AU - Seeger, W
AU - Schmeißer, A
AU - Harbaum, L
AU - Buerke, M
AU - Ghofrani, H Ardeschir
AU - Borst, M M
AU - Leuchte, H H
AU - Lange, T J
AU - Behr, J
AU - Ulrich, S
AU - Lang, I
AU - Olschewski, H
AU - Gall, H
AU - Kabitz, H-J
AU - Kleber, F-X
AU - Held, M
AU - Hoeper, M M
AU - Grünig, E
PY - 2014/12/1
Y1 - 2014/12/1
KW - Adult
KW - Antihypertensive Agents
KW - Combined Modality Therapy
KW - Cooperative Behavior
KW - Drug Approval
KW - Drug Therapy, Combination
KW - Endothelin Receptor Antagonists
KW - Evidence-Based Medicine
KW - Humans
KW - Hypertension, Pulmonary
KW - Interdisciplinary Communication
KW - Molecular Targeted Therapy
KW - Phosphodiesterase 5 Inhibitors
KW - Pyrazoles
KW - Pyrimidines
KW - Randomized Controlled Trials as Topic
KW - Survival Rate
KW - Treatment Outcome
U2 - 10.1055/s-0034-1387489
DO - 10.1055/s-0034-1387489
M3 - SCORING: Zeitschriftenaufsatz
C2 - 25489684
VL - 139 Suppl 4
SP - S142-50
JO - DEUT MED WOCHENSCHR
JF - DEUT MED WOCHENSCHR
SN - 0012-0472
ER -
